Trials / Unknown
UnknownNCT05995418
Study on the Health Economic Burden of Alzheimer's Disease in China
Monetary Costs of Alzheimer's Disease in China: Protocol for a Cluster-randomized Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,510 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 40 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multi-center and cross-sectional study. Using standardized case report forms, we randomly selected suitable patients from the cognitive centers of provincial administrative units in Chinese mainland to conduct a questionnaire survey, so as to obtain relevant information about their economic burden.
Detailed description
Under the policy background of building a national cognitive center, this study collected and evaluated the socio-demographic characteristics, geographical location, regional socio-economic development level, family support, medical resources, related behaviors, nursing environment, patients' health behaviors, current medical history, past history, drug use, family history and clinical diagnosis of Alzheimer's patients in inland provinces and cities of China, and made statistics on the related information of patients' health economics. To form a comprehensive assessment of the health economic burden of Alzheimer's disease in China, the primary objectives of the study are as follows: 1. Comprehensively assess the health economic burden of Alzheimer's disease, including medical and non-medical costs. 2. Explore the economic burden of Alzheimer's disease in different stages, including mild cognitive impairment stage, mild to moderate Alzheimer's disease stage and severe Alzheimer's disease stage. 3. To explore the health economic burden of the comorbidity of Alzheimer's disease and other chronic diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | There was no intervention as this was an observational study. | There was no intervention as this was an observational study. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2024-04-01
- Completion
- 2024-08-01
- First posted
- 2023-08-16
- Last updated
- 2023-08-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05995418. Inclusion in this directory is not an endorsement.